No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Startup Hernia Mesh Company Highlights Previous Hernia Repair Mesh Failures

A new product has been approved by the FDA that could reduce the percentage of hernia repair mesh failure from products like Physiomesh

Monday, August 24, 2020 - According to startup medical device manufacturer Deep Blue Medical, the company has come up with a solution to one aspect of hernia repair mesh malfunctions. Surgeons mostly use laparoscopic hernia mesh repair equipment that is difficult to perform the intricate hernia repair surgery and also difficult to tie the sutures in place to securely affix hernia repair mesh in place. Blue Medical's T-Line hernia repair mesh is attempting to solve the problem of hernia repair mesh failing at the point of being stitched on to the underlying tissues. Blue medical claims that hernia mesh failure at those anchor points account for the majority of hernia repair mesh failure. Hernia repair mesh lawsuit claims continue to be filed nationwide and attorneys handling these cases are offering a free consultation with no obligation.

The T-Line hernia repair mesh has 14 suture anchor points compared to 4 to 6 for most other hernia repair mesh devices. T-Line hernia repair mesh is implanted using traditional open surgery and does not require the experience or skill in operating the microscope computer surgical equipment. The sutures themselves are made from hernia repair mesh instead of separate suture material and the company claims that fact will add to the hernia repair mesh staying in place longer than most. One problem that the device does not solve, however, is that it is polypropylene, a plastic that may not be a suitable material for implantation with the body. The shortcomings of polypropylene are well-documented in thousands of lawsuits against companies like Boston Scientific, Johnson & Johnson, American Medical Systems, and C.R. Bard, to name just a few, that claim that the transvaginal mesh device failed because of the device's incompatibility with human tissue.

Thousands of individuals that have had hernia repair surgery using Ethicon Physiomesh or other polypropylene hernia mesh devices have reported being left in severe pain that requires a second revision surgery or more. Hernia repair mesh can tear away from the surgical site and migrate down to the bowels, causing dangerous blockages, lacerations, and infections. Often the sutures that act as anchor points will fail and allow the mesh to break free. The Physiomesh Composite Hernia mesh tried to solve that problem by the nature of its construction. One complete side of Physiomesh was polypropylene plastic used because of its uncommon strength and flexibility, and the other from natural tissues that were to become absorbed into the underlying tissue. Over the long-term, the degradation of the polypropylene component may have caused the device to buckle, crumple, and otherwise calcify and rejected as a foreign object by the body's natural immune system. Mesh Medical Devices News reports that OSHA's Material Safety Data Sheet warns "Do not use this Phillips Sumika Polypropylene Company material in medical applications involving permanent implantation in the human body or permanent contact with internal body fluids or tissues." In 2016, Ethicon, a subsidiary of Johnson & Johnson, was voluntarily recalled Ethicon Physiomesh Composite Hernia Repair Mesh over complaints made in Europe of patients requiring revision surgeries.

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. OnderLaw has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. OnderLaw has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.